NXG.V NexgenRX Inc.

Healthcare Health Care Providers & Services TSX Venture Exchange
0.6600 CAD
Close of Nov 7, 2026
0.2820 0.7388
Market cap
CAD 46.9M
P/E
22.0x
P/B
6.07x
ROE
47.3%
Dividend yield
2.76%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is NXG.V undervalued?

Graham number
Price0.6600
Graham value0.2710
Premium143.5%

NXG.V trades 143.5% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

NexgenRX Inc. fundamental analysis

No fundamental analysis for NexgenRX Inc. yet.

NexgenRX Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About NexgenRX Inc.

NexgenRx Inc. administers, adjudicates, and pays drug, dental, and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers in Canada. The company offers NexSys claims management; NexAdmin plan administration; and NexPSPAssist patient support programs. It also provides proprietary computer software, and ancillary services. NexgenRx Inc. was incorporated in 2003 and is headquartered in Toronto, Canada.

Full company profile